Drug Designing Tools Market Overview
The Drug Designing Tools Market size is forecast to reach $3.8 billion by 2026, growing at a CAGR of 10.6% during the forecast period 2021-2026. Drug designing tools provide insights into experimental findings. It discovers, enhances, and studies drugs-related to biologically active molecules by structure-based drug design and ligand-based drug design. The market relies on the knowledge of the 3D structure of the biological target obtained through various methods. The rising need for more effective drugs and the adoption of advanced technologies in drug designing along with the growing need for cost and time-effective tools are the major factors driving the growth of the market. Molecular modelling, computer-aided designs, and bioinformatics tools are set to further enhance the overall market demand for the Drug Designing Tools Market for the period 2021-2026.
The report: “Drug Designing Tools Market Forecast (2021-2026)”, by Industry ARC, covers an in-depth analysis of the following segments of the Drug Designing Tools Market.
By Solution: Multi Databases, Virtual Screening Tools, Structure Designing, Predictive Analysis, Model Building Tools, and Others.
By Application: Chemical Screening, Molecular Modelling, Target Prediction, Binding Site Prediction, Docking, and Others.
By End Users: Pharmaceutical Companies, Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations, and Others.
By Geography: North America (U.S., Canada, Mexico), Europe (Germany, United Kingdom (U.K.), France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific ((APAC (China, Japan India, South Korea, Australia and New Zealand, and Rest of APAC)), South America (Brazil, Argentina, and Rest of South America), and Rest of the World ((RoW) (Middle East, and Africa)).
- North America dominated the Drug Designing Tools Market in 2020 owing to the increased research & development in healthcare and through advancing technological developments. The Drug Designing Tools Market scope for different regions will be provided in the final report.
- Rising use of intelligent enterprise techniques for the purposes of drug designing and increasing drug designing tools are likely to aid the market growth of the Drug Designing Tools Market.
- Detailed analysis of the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Drug Designing Tools Market report.
- Infrastructure compatibility is poised to create hurdles for the Drug Designing Tools Market.
Drug Designing Tools Market Segment Analysis – By Solution
Virtual Screening held the largest share in the Drug Designing Tools Market in 2020 and is estimated to grow at a CAGR 13.8% during the forecast period 2021-2026. Virtual screening is used for helping in drug discovery processes and for the identification of novel bioactive compounds by screening large molecular databases. It is a computer-aided method that can save time and costs in the drug development process and it also reduces the failure rate by prioritizing compounds. Structure-based virtual screening uses molecular docking techniques to screen large virtual libraries and the compounds are scored based on the predicted interactions with the target. Virtual Screening is set to be the highest growing segment and is estimated to register the highest CAGR over the period 2021-2026.
Drug Designing Tools Market Segment Analysis – By Application
Molecular Modelling held the largest share in the Drug Designing Tools Market in 2020 and is estimated to grow at a CAGR 9.9% during the forecast period 2021-2026. Molecular modelling is a theoretical method and computational technique to model the behavior of molecules and their properties into databases. Molecular modelling permeates all aspects of drug designs. Target prediction has a significant role in the drug discovery process that aims to identify the new drug compounds for biological targets and binds to the target molecule by forming temporary bonds. Target Prediction is set to be the highest growing segment and is estimated to register the highest CAGR over the period 2021-2026.
Drug Designing Tools Market Segment Analysis – By Geography
North America dominated Drug Designing Tools Market with a major share of 46.3% in 2020. This is attributed to the increasing research & development in healthcare and advancing technological developments. The rising use of intelligent enterprise techniques for the purpose of drug designing and various biotechnology & pharmaceutical companies use drug discovery tools to limit the use of resources and reduce the time for their drug development processes is increasing the growth of the market in this region. However, Asia Pacific is estimated to grow at a higher CAGR during the forecast period 2021-2026 owing to the growing number of academic institutes which are end-user of drug designing tools along with the huge investments made in drug designing tools and growing awareness regarding the clinical phases.
Drug Designing Tools Market Revenue Share, By Geography, 2020(%)
Drug Designing Tools Market Drivers
Adoption of Advanced Technologies in Drug Designing
The adoption of advanced technologies in drug designing is increasing the growth of the Drug Designing Tools Market. This is attributed to the increasing size of chemical libraries, high-throughput screening, and increase in compounds for optimization. Genome-based therapeutics is a new advancing technology that has the potential to develop and identify the new drug targets to pursue. It has helped developers by understanding the mechanisms of diseases as well as individual patient's reactions to the medications. Therapeutic antibodies activate, repress, or alter endogenous immune responses to specific molecule. Thus, increasing the growth of the Drug Designing Tools Market during the forecast period 2021-2026.
Increasing Drug Designing Tools
Increasing drug designing tools are increasing the growth of the Drug Designing Tools Market. This is attributed to the software-based methods such as molecular modelling, structure-based virtual screening, and molecular dynamics that are considered to be a powerful tool for the investigation of pharmacodynamics properties of drugs. Drug designing tools are fast, accurate, and it also provides valuable insights into experimental findings. Thus, increasing the growth of the Drug Designing Tools Market during the forecast period 2021-2026.
Drug Designing Tools Market Challenges
Some of the factors that are set to impede the growth of the Drug Designing Tools Market are infrastructure compatibility.Lack of validated diagnostic and therapeutic biomarkers to objectively detect and measure biological states along with the costly process is set to hinder the growth of the market.
Drug Designing Tools Market Landscape
Product launches, mergers and acquisitions, joint ventures, and R&D activities are key strategies adopted by players in the Drug Designing Tools Market. In 2020, the Drug Designing Tools Market share is consolidated by the top ten players present in the market. Drug Designing Tools Market, top 10 companies are Agilent Technologies, Schrodinger LLC, Biovia Corporation, Bio Solve IT GmbH, CosmoLogic GmbH, Novo Informatics Pvt. Ltd., Open Eye Scientific Software Inc., XtalPi Inc., Albany Molecular Research Inc., and Chem Axon among others.
Report Code: HCR 0023
Report Code: HCR 0309
For more Lifesciences and Healthcare Market reports, Please click here
1.Drug Designing Tools Market - Overview
1.1 Definitions and Scope
2.Drug Designing Tools Market - Executive Summary
2.1 Market Revenue and Key Trends 2019 by Company
2.2 Key Trends by Solution
2.3 Key Trends by Application
2.4 Key Trends by End User
2.5 Key Trends by Geography
3. Drug Designing Tools Market – Comparative Analysis
3.1 Product Benchmarking – Key Companies
3.2 Financial Analysis – Key Companies
3.3 Market Value Split by Key Companies
3.4 Patent Analysis – Key Companies
3.5 Pricing Analysis
4. Drug Designing Tools Market - Startup Companies Scenario Premium
4.1 Key Startup Company Analysis by
4.1.3 Venture Capital and Funding Scenario
5. Drug Designing Tools Market – Industry Market Entry Scenario Premium Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case Studies of Successful Ventures
6. Drug Designing Tools Market Forces
6.1 Market Drivers
6.2 Market Constraints/Challenges
6.3 Porters five force model
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7. Drug Designing Tools Market – Strategic Analysis
7.1 Value Chain Analysis
7.2 Opportunities Analysis
7.3 Market Life Cycle
8. Drug Designing Tools Market – By Solution(Market Size –$Million/$Billion)
8.1 Multi Databases
8.2 Virtual Screening Tools
8.3 Structure Designing
8.4 Predictive Analysis
8.5 Model Building Tools
9. Drug Designing Tools Market – By Application (Market Size –$Million/$Billion)
9.1 Chemical Screening
9.2 Molecular Modeling
9.3 Target Prediction
9.4 Binding Site Prediction
10. Drug Designing Tools Market – By End User(Market Size –$Million/$Billion)
10.1 Pharmaceutical Companies
10.3 Academic and Research Institutes
10.4 Contract Research Organizations
11. Drug Designing Tools Market - By Geography(Market Size –$Million/$Billion)
11.1 North America
11.2.6 Rest of Europe
11.3 Asia Pacific
11.3.4 South Korea
11.3.5 Australia & New Zealand
11.3.6 Rest of APAC
11.4 South America
11.4.3 Rest of South America
11.5 Rest of the World
11.5.1 Middle East
12. Drug Designing Tools Market - Entropy
13. Drug Designing Tools Market – Industry/Segment Competition Landscape Premium
13.1 Market Share Analysis
13.1.1 Global Market Share – Key Companies
13.1.2 Market Share by Region – Key companies
13.1.3 Market Share by Countries – Key Companies
13.1.4 Best Practices for Companies
14. Drug Designing Tools Market – Key Company List by Country Premium Premium
15. Drug Designing Tools Market Company Analysis
15.1 Company 1
15.2 Company 2
15.3 Company 3
15.4 Company 4
15.5 Company 5
15.6 Company 6
15.7 Company 7
15.8 Company 8
15.9 Company 9
15.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.